FDA Clearance Tracker · K220480
Revogene
Last checked: Nov 19, 2026Latest source record: Jul 11, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Jul 11, 2022
Substantially Equivalent
Time to decision
143 days
Received Feb 18, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K220480
- Device name
- Revogene
- Applicant
- Meridian Bioscience, Inc.
- Applicant location
- Cincinnati, OH
- Received
- Feb 18, 2022
- Decided
- Jul 11, 2022
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 862.2570
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OOI. The earliest in FDA's data is K092705, decided May 28, 2010.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K220480
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Meridian Bioscience, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Revogene510(k)
K243922 · Decided Mar 20, 2025 · 90 days after receipt
Device type: Real Time Nucleic Acid Amplification System (OOI) · Laboratory Medicine & Pathology
K230901 · Decided Jul 3, 2023 · 94 days after receipt
Device type: Helicobacter Pylori (LYR) · Laboratory Medicine & Pathology
- Curian® Shiga Toxin510(k)
K222829 · Decided Apr 17, 2023 · 210 days after receipt
Device type: Antigens, All Types, Escherichia Coli (GMZ) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.